CSL Bulk Human Coagulation Factor VIII 500 IU (50 IU/mL) / von Willebrand factor 1200 IU powder for injection vial

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
26-11-2017

有効成分:

Von willebrand factor, Quantity: 1200 IU; Factor VIII, Quantity: 500 IU

から入手可能:

CSL Behring Australia Pty Ltd

INN(国際名):

Factor VIII,Von willebrand factor

医薬品形態:

Injection, powder for

構図:

Excipient Ingredients: sodium citrate dihydrate; trometamol; calcium chloride dihydrate; Albumin; sucrose; sodium chloride

投与経路:

Intravenous

適応症:

von Willebrand disease (VWD) - Treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with VWD, when desmopressin (DDAVP) treatment alone is ineffective or contraindicated. Haemophilia A (congenital FVIII deficiency) - Prophylaxis and treatment of bleeding in patients with haemophilia A.

製品概要:

Visual Identification: A white or pale yellow, hygroscopic powder or friable solid; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

認証ステータス:

Licence status A

承認日:

2013-09-02